| 3-D Model Of Esophageal Cancer Created
ScienceDaily (Nov. 21, 2007) A team of scientists led by Dr. Anil Rustgi (UPenn) presents an innovative new model of esophageal cancer, which holds great promise as an experimental platform to investigate the etiology and possible treatment of this devastating disease. .
Mehdi Shahbazi, 65; gas station operator fought with Shell Oil over ...
Mehdi Shahbazi, 65, a gasoline station operator who waged a hunger strike and public relations battle against high gasoline prices and the fees that oil firms charge franchisees, died Wednesday at Stanford Hospital of liver failure.
Shahbazi leased a Shell station in Central California in 1982. In 2005, he posted signs at the Marina station highlighting "big oil's unearned profit" -- a protest that Shell said violated the terms of his lease. Shell sued, then Shahbazi accused the company of breach of contract and of violating the Petroleum Marketing Practices Act.
In July, he went on a liquids-only diet to underscore what he called onerous franchise fees and other problems faced by individual gas station operators.
He refused to sell gas, instead inviting customers to spend money at the store's mini-mart and carwash.
Different Diwali
Both the groups approach from two different sides and converge shouting religious slogans. The devotees try to get hold the sacred stick. The team which pulls the crowd to their side and if one amongst them snatches the stick and tosses it into air and it lands on the ground, is the winner. In the evening, it is mandatory for one member of a Brahmin family to accompany the devta procession to Shantha. The devta is a special guest of Shatbahi Devi Temple there. At least, one family member has to sit through the night in the temple premises of the devi where puja and oracle sessions are held. The guests dance in front the bonfire till morning that heralds a �bright darknessless night� and symbolises triumph of light over darkness. After blessings by devis and devtas, the procession returns to temple at Batewari.
Human Genome Sciences Announces Full Presentation Of Quality-of-Life ...
Human Genome Sciences, Inc. (Nasdaq: HGSI) announced the final quality-of-life results from a Phase 2b clinical trial of the investigational drug, Albuferon(R) (albinterferon alfa-2b), in combination with ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C. The study demonstrated that patients in the Albuferon treatment groups reported fewer missed days of work and less impairment of health-related quality of life on treatment compared to the Pegasys (peginterferon alfa-2a) group.
The final Phase 2b quality-of-life results are being presented this week at the 58th AASLD Annual Meeting in Boston. In two additional press releases issued by HGS today, the Company announced the full presentations at AASLD of efficacy and safety data from the Phase 2b trial of Albuferon in treatment- naive patients, and results from the Phase 2 trial of Albuferon in combination with ribavirin in patients who did not respond to prior therapy.
Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial ...
CHICAGO, Nov. 15 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (NASDAQ: ADLS) , today announced positive results from Trial CL-05, the second of two pivotal phase III clinical trials designed to assess the safety and effectiveness of cethromycin, a novel once-a-day oral antibiotic for the treatment of mild-to-moderate community acquired pneumonia (CAP), the sixth leading cause of death in the United States. The primary efficacy endpoint of statistical non-inferiority in the clinical cure rate at the test-of-cure visit was achieved. The study results showed that cethromycin cured 94.0% of patients with CAP, compared to Biaxin(R) (clarithromycin), a current standard of care treatment for CAP, which cured 93.8% of studied patients in the per protocol population. In the modified intent to treat population, cethromycin cured 83.1% of patients and Biaxin cured 81.1%.
Cancer-striken boy writes book
Sean Collins, shown in undated handout photo, poses for a photo with his dog Emily and parents Lisette Richard and Chris Collins. Sean, who lost his battle against a rare and aggressive form of cancer earlier this year, just a few days after his 13th birthday, left behind a book about his ordeal which offers a rare glimpse into the thoughts and feelings of a small, brave boy facing the terror of childhood cancer. THE CANADIAN PRESS/HO - Daniel St. Louis .
|
